SC Filed 2018-02-14 Event — SEC 0001104659-18-009728 →

HealthCare Ventures IX, L.P. → LEAP THERAPEUTICS, INC. CYPH

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

8 transactions

8 buys · 0 sales · 0 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

2 filings by this filer

1 other filing in the data moat

Short Interest · settle 2026-07-31

DTC 6.13

7,297,921 shares short · -9.9% vs prior

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-07-01	Richard Christian M	director	Award	75,000	—	—
2026-07-01	Oei Khing Djien	director	Award	100,000	—	—
2026-07-01	Dietz Thomas John	director	Award	100,000	—	—
2026-07-01	Martin Patricia A.	director	Award	75,000	—	—
2026-07-01	LI WILLIAM	director	Award	75,000	—	—
2026-07-01	ONSI DOUGLAS E	director, officer	Award	1,000,000	—	—
2026-07-01	McEvoy William Patrick III	director, officer, 10%+ owner	Award	1,000,000	—	—
2026-07-01	Mashiach Nissim	director	Award	75,000	—	—

Other 13D/G Filings on LEAP THERAPEUTICS, INC.

Filed	Form	Filer	Stake	Shares
2026-08-19	SCHEDULE 13D/A	Winklevoss Capital Fund, LLC	19.90%	24,854,613	view →
2021-09-29	SC	BeiGene, Ltd.	—	—	view →
2020-01-21	SC	Valence Helix Investments III, LLC	—	—	view →
2019-02-08	SC	HealthCare Ventures IX, L.P.	—	—	view →

Other Filings by HealthCare Ventures IX, L.P.

Filed	Form	Issuer	Stake	Shares
2019-02-08	SC	LEAP THERAPEUTICS, INC. CYPH	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →